Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

A new study suggests that popular weight loss drugs may reduce the risk of suicide in adolescents. KYW medical editor Dr. Brian McDonough has more.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.

New research reveals that popular diabetes and weight-loss drugs may also protect the kidneys. This groundbreaking study, ...

WHILE the price of the same medication may be expensive in one pharmacy and very cheap in another, it may not be as a result ...

The myth of ‘big-boned’ continues to this day, leading to many unhealthy habits, practices, and lifestyles among the ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...